Absci (ABSI) Stock Price, Quote, News & History | Benzinga

Absci Corp (ABSI) Stock Price, Quote, News & History

ABSINASDAQ

Trade with Public

Trade with Public

$8.84

-0.71-7.43%

At close: Aug 24, 5:00 PM EST

$8.86

0.01560.18%

After Hours: 6:56 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$9.33

Close

$8.84

Volume / Avg.

2.20M / 4.99M

Day Range

$8.75 - $9.36

52 Wk Range

2.24 - 12.06

Market Cap

$1.52B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

26.45%

Days to Cover

11.65

Recent Absci Corp News

National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 results and Captivate Holdings acquisition. Other stocks also falling in pre-market trading.

Avi Kapoor

Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI

Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A decline, signaling a shift in AI adoption.

Surbhi Jain

Micron To Rally More Than 57%? Here Are 10 Top Analyst Forecasts For Thursday

Top analysts changed outlook on top names. See full changes, upgrades, downgrades on analyst ratings page. See how analysts view PepsiCo, Absci, Okta, Datadog, ICON, Nike, UWM, Micron.

Avi Kapoor

KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares jumped 16.2%. Other big gainers: WEN, ABSI, RUN, CCXI, ENRD, SFTX, ICCM, INMD, DFH.

Avi Kapoor

Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program

Absci reported positive interim Phase 1 ABS-201 data and priced a $100 million stock offering to advance development.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-108.08M

Investing Cash Flow (TTM)

-12.73M

Financing Cash Flow (TTM)

174.44M

Free Cash Flow (TTM)

-108.97M

Capital Expenditure (TTM)

-890.00K

Net Change in Cash (TTM)

53.63M

Analyst Trends and Forecast

3

Mar

2

May

5

Jun

1

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.44B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

926.53

PB Ratio (TTM)

6.66

Earnings Yield % (TTM)

-8.27%

Earnings Yield % (FWD)

-8.16%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.43

Company Debt

Total Debt

$150.00K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$2.00M

Total Cash

$107.87M

Debt to Equity

0.02

Issuance of Debt (TTM)

-$2.00M

Repayment of Debt (TTM)

-$2.00M

Key Statistics

Open

$9.33

Close

$8.84

Volume / Avg.

2.20M / 4.99M

Day Range

$8.75 - $9.36

52 Wk Range

2.24 - 12.06

Market Cap

$1.52B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

26.45%

Days to Cover

11.65

About

Sector

Health Care

Industry

Biotechnology

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line devel...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Absci (ABSI) stock?

A

You can purchase shares of Absci (NASDAQ:ABSI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Absci (ABSI) competitors?

A

Other companies in Absci’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Absci (ABSI) stock?

A

Absci has a consensus price target of $12.09.

Q

What is the current price for Absci (ABSI)?

A

The stock price for Absci (NASDAQ: ABSI) is $8.8556 last updated August 24, 2026 at 6:56 PM EDT.

Q

Does Absci (ABSI) pay a dividend?

A

There are no upcoming dividends for Absci.

Q

When is Absci (NASDAQ:ABSI) reporting earnings?

A

Absci does not have any upcoming earnings scheduled.

Q

Is Absci (ABSI) going to split?

A

There is no upcoming split for Absci.

Q

What sector and industry does Absci (ABSI) operate in?

A

Absci is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.